VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Edwards Lifesciences Corporation vs Meta Platforms, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Edwards Lifesciences Corporation
EW · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Edwards Lifesciences Corporation's moat claims, evidence, and risks.
View EW analysisMeta Platforms, Inc.
META · Nasdaq Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Meta Platforms, Inc.'s moat claims, evidence, and risks.
View META analysisComparison highlights
- Moat score gap: Meta Platforms, Inc. leads (94 / 100 vs 82 / 100 for Edwards Lifesciences Corporation).
- Segment focus: Edwards Lifesciences Corporation has 3 segments (75.5% in Transcatheter Aortic Valve Replacement (TAVR)); Meta Platforms, Inc. has 2 segments (98.7% in Family of Apps (FoA)).
- Moat breadth: Edwards Lifesciences Corporation has 6 moat types across 3 domains; Meta Platforms, Inc. has 6 across 2.
Primary market context
Edwards Lifesciences Corporation
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) devices
Global
Hospitals and structural heart centers
Medical device manufacturer
75.5%
Meta Platforms, Inc.
Family of Apps (FoA)
Global social media platforms & social media advertising
Global
Consumers and advertisers
Two-sided platform (attention + ad auction)
98.7%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Edwards Lifesciences Corporation strengths
Meta Platforms, Inc. strengths
Segment mix
Edwards Lifesciences Corporation segments
Full profile >Transcatheter Aortic Valve Replacement (TAVR)
Oligopoly
Transcatheter Mitral and Tricuspid Therapies (TMTT)
Competitive
Surgical Structural Heart
Oligopoly
Meta Platforms, Inc. segments
Full profile >Family of Apps (FoA)
Oligopoly
Reality Labs (RL)
Quasi-Monopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.